Protalix BioTherapeutics (PLX) Share-based Compensation (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.32% |
| Dec 31, 2025 | 22.41% |
| Sep 30, 2025 | 40.05% |
| Jun 30, 2025 | -20.93% |
| Mar 31, 2025 | -17.43% |
| Dec 31, 2024 | 5.48% |
| Sep 30, 2024 | -37.88% |
| Jun 30, 2024 | 1.73% |
| Mar 31, 2024 | -28.24% |
| Dec 31, 2023 | 89.86% |
| Sep 30, 2023 | 190.32% |
| Jun 30, 2023 | -54.58% |
| Mar 31, 2023 | 1.30% |
| Dec 31, 2022 | 1,397.22% |
| Sep 30, 2022 | -79.43% |
| Jun 30, 2022 | -79.07% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | 21.51% |
| Sep 30, 2021 | -8.27% |
| Jun 30, 2021 | -54.04% |
| Mar 31, 2021 | -19.53% |
| Dec 31, 2020 | 19.01% |
| Sep 30, 2020 | 213.24% |
| Jun 30, 2020 | -36.89% |
| Mar 31, 2020 | 82.63% |
| Dec 31, 2019 | 174.42% |
| Sep 30, 2019 | -37.68% |
| Jun 30, 2019 | -52.41% |
| Mar 31, 2019 | -30.62% |
| Dec 31, 2018 | 3,085.71% |
| Sep 30, 2018 | -200.00% |
| Jun 30, 2018 | -77.42% |
| Mar 31, 2018 | 34.78% |
| Dec 31, 2017 | -38.67% |
| Sep 30, 2017 | -23.47% |
| Jun 30, 2017 | -16.95% |
| Mar 31, 2017 | -47.09% |
| Dec 31, 2016 | 36.81% |
| Sep 30, 2016 | -28.19% |
| Jun 30, 2016 | -39.47% |
| Mar 31, 2016 | -2.09% |
| Dec 31, 2015 | -14.13% |
| Sep 30, 2015 | -19.49% |
| Jun 30, 2015 | 32.22% |
| Mar 31, 2014 | 5.35% |
| Dec 31, 2013 | -33.33% |
| Sep 30, 2013 | -15.72% |
| Jun 30, 2013 | -17.19% |
| Mar 31, 2013 | -18.92% |
| Dec 31, 2012 | -56.77% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 2,923.26% |
| Mar 31, 2012 | -17.31% |
| Dec 31, 2011 | 69.57% |
| Sep 30, 2011 | -27.56% |
| Jun 30, 2011 | -47.52% |
| Mar 31, 2011 | -38.73% |
| Dec 31, 2010 | 178.17% |
| Sep 30, 2010 | -5.96% |